If you were treated for stress urinary incontinence (SUI) or pelvic organ prolapse (POP) between the years 2005 and 2010, you were likely implanted with transvaginal mesh, which may make you eligible to pursue a transvaginal mesh lawsuit.

According to a study published Nov. 19, 2012 in the American Journal of Obstetrics & Gynecology, 74.9 percent of prolapse surgeries performed during that time utilized this material, which is surgically stitched to the patient’s vaginal wall to treat the above conditions.

That irons out to an overall rate of 56.9 per 100,000 person-years, the study revealed. Findings of this research were based on claims data that examined trends in vaginal mesh prolapse procedures (VMS), minimally invasive sacrocolpopexy (MISC) and abdominal sacrocolpopexy (ASC).

Now, two years later, 8,000 transvaginal mesh lawsuits have been filed in federal court, and are currently pending before a single judge in the U.S. District Court for the Southern District of West Virginia.  

Transvaginal mesh lawsuits have been brought by women who sustained one or more of the following side effects after undergoing a transvaginal mesh surgery:

  • pain
  • mesh erosion
  • infection
  • urinary problems
  • pain during intercourse
  • recurrence of pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI)

In the Court, multidistrict litigations (MDL) have been established for cases filed against the following transvaginal mesh manufacturers: American Medical Systems, C.R. Bard Inc., Johnson & Johnson subsidiary, Ethicon and Boston Scientific Corp.

Some lawsuits filed over vaginal mesh devices marketed by Ethicon and C.R. Bard are currently being held in New Jersey Superior Court.

And that is not all. A recent editorial by Ring of Fire radio published Dec. 6 said the number of transvaginal mesh lawsuits is expected to reach 10,000 by early next year.

Published December 11, 2012 by